NCT07309419 2025-12-30Cocktail-001Shanghai Zhongshan HospitalPhase 2/3 Not yet recruiting222 enrolled
NCT05976568 2023-08-04A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaQilu Pharmaceutical Co., Ltd.Phase 2/3 Not yet recruiting668 enrolled